Global Amlodipine Besylate Market Insights, Forecast to 2025

Publisher Name :
Date: 18-Jun-2019
No. of pages: 126
Inquire Before Buying

Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension and Coronary Artery Disease.

The global Amlodipine Besylate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Amlodipine Besylate market based on company, product type, end user and key regions.

This report studies the global market size of Amlodipine Besylate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Amlodipine Besylate in these regions.

This research report categorizes the global Amlodipine Besylate market by top players/brands, region, type and end user. This report also studies the global Amlodipine Besylate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Pfizer

- Mylan

- Dr. Reddy's Laboratories

- Apotex

- Teva Pharmaceutical

- Cipla

- Hikma Pharmaceuticals

- Strides Pharma

- Upsher-Smith Laboratories

- InvaGen Pharmaceuticals

- Sun Pharmaceutical

- Aurobindo Pharma

- Lupin Pharmaceuticals

- Zydus Pharmaceuticals

- Oxford Pharm

- Wockhardt

- Epic Pharma

- CR Pharmaceutical

- Alkem Laboratories

- MACLEODS

Market size by Product

- 2.5mg Tablets

- 5mg Tablets

- 10mg Tablets

Market size by End User

- High Blood Pressure

- Heart Disease

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Amlodipine Besylate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Amlodipine Besylate market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Amlodipine Besylate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Amlodipine Besylate submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amlodipine Besylate are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amlodipine Besylate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Amlodipine Besylate Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Amlodipine Besylate Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Amlodipine Besylate Market Size Growth Rate by Product
1.4.2 2.5mg Tablets
1.4.3 5mg Tablets
1.4.4 10mg Tablets
1.5 Market by End User
1.5.1 Global Amlodipine Besylate Market Size Growth Rate by End User
1.5.2 High Blood Pressure
1.5.3 Heart Disease
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Amlodipine Besylate Market Size
2.1.1 Global Amlodipine Besylate Revenue 2014-2025
2.1.2 Global Amlodipine Besylate Sales 2014-2025
2.2 Amlodipine Besylate Growth Rate by Regions
2.2.1 Global Amlodipine Besylate Sales by Regions
2.2.2 Global Amlodipine Besylate Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Amlodipine Besylate Sales by Manufacturers
3.1.1 Amlodipine Besylate Sales by Manufacturers
3.1.2 Amlodipine Besylate Sales Market Share by Manufacturers
3.1.3 Global Amlodipine Besylate Market Concentration Ratio (CR5 and HHI)
3.2 Amlodipine Besylate Revenue by Manufacturers
3.2.1 Amlodipine Besylate Revenue by Manufacturers (2014-2019)
3.2.2 Amlodipine Besylate Revenue Share by Manufacturers (2014-2019)
3.3 Amlodipine Besylate Price by Manufacturers
3.4 Amlodipine Besylate Manufacturing Base Distribution, Product Types
3.4.1 Amlodipine Besylate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amlodipine Besylate Product Type
3.4.3 Date of International Manufacturers Enter into Amlodipine Besylate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Amlodipine Besylate Sales by Product
4.2 Global Amlodipine Besylate Revenue by Product
4.3 Amlodipine Besylate Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Amlodipine Besylate Breakdown Data by End User
6 North America
6.1 North America Amlodipine Besylate by Countries
6.1.1 North America Amlodipine Besylate Sales by Countries
6.1.2 North America Amlodipine Besylate Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Amlodipine Besylate by Product
6.3 North America Amlodipine Besylate by End User
7 Europe
7.1 Europe Amlodipine Besylate by Countries
7.1.1 Europe Amlodipine Besylate Sales by Countries
7.1.2 Europe Amlodipine Besylate Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Amlodipine Besylate by Product
7.3 Europe Amlodipine Besylate by End User
8 Asia Pacific
8.1 Asia Pacific Amlodipine Besylate by Countries
8.1.1 Asia Pacific Amlodipine Besylate Sales by Countries
8.1.2 Asia Pacific Amlodipine Besylate Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Amlodipine Besylate by Product
8.3 Asia Pacific Amlodipine Besylate by End User
9 Central & South America
9.1 Central & South America Amlodipine Besylate by Countries
9.1.1 Central & South America Amlodipine Besylate Sales by Countries
9.1.2 Central & South America Amlodipine Besylate Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Amlodipine Besylate by Product
9.3 Central & South America Amlodipine Besylate by End User
10 Middle East and Africa
10.1 Middle East and Africa Amlodipine Besylate by Countries
10.1.1 Middle East and Africa Amlodipine Besylate Sales by Countries
10.1.2 Middle East and Africa Amlodipine Besylate Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Amlodipine Besylate by Product
10.3 Middle East and Africa Amlodipine Besylate by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Amlodipine Besylate Products Offered
11.1.5 Pfizer Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Company Business Overview
11.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Mylan Amlodipine Besylate Products Offered
11.2.5 Mylan Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Products Offered
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Company Business Overview
11.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Apotex Amlodipine Besylate Products Offered
11.4.5 Apotex Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Teva Pharmaceutical Amlodipine Besylate Products Offered
11.5.5 Teva Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Company Business Overview
11.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Cipla Amlodipine Besylate Products Offered
11.6.5 Cipla Recent Development
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Hikma Pharmaceuticals Amlodipine Besylate Products Offered
11.7.5 Hikma Pharmaceuticals Recent Development
11.8 Strides Pharma
11.8.1 Strides Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Strides Pharma Amlodipine Besylate Products Offered
11.8.5 Strides Pharma Recent Development
11.9 Upsher-Smith Laboratories
11.9.1 Upsher-Smith Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Upsher-Smith Laboratories Amlodipine Besylate Products Offered
11.9.5 Upsher-Smith Laboratories Recent Development
11.10 InvaGen Pharmaceuticals
11.10.1 InvaGen Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2014-2019)
11.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Products Offered
11.10.5 InvaGen Pharmaceuticals Recent Development
11.11 Sun Pharmaceutical
11.12 Aurobindo Pharma
11.13 Lupin Pharmaceuticals
11.14 Zydus Pharmaceuticals
11.15 Oxford Pharm
11.16 Wockhardt
11.17 Epic Pharma
11.18 CR Pharmaceutical
11.19 Alkem Laboratories
11.20 MACLEODS
12 Future Forecast
12.1 Amlodipine Besylate Market Forecast by Regions
12.1.1 Global Amlodipine Besylate Sales Forecast by Regions 2019-2025
12.1.2 Global Amlodipine Besylate Revenue Forecast by Regions 2019-2025
12.2 Amlodipine Besylate Market Forecast by Product
12.2.1 Global Amlodipine Besylate Sales Forecast by Product 2019-2025
12.2.2 Global Amlodipine Besylate Revenue Forecast by Product 2019-2025
12.3 Amlodipine Besylate Market Forecast by End User
12.4 North America Amlodipine Besylate Forecast
12.5 Europe Amlodipine Besylate Forecast
12.6 Asia Pacific Amlodipine Besylate Forecast
12.7 Central & South America Amlodipine Besylate Forecast
12.8 Middle East and Africa Amlodipine Besylate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amlodipine Besylate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Amlodipine Besylate Product Picture
Table Amlodipine Besylate Market Segments
Table Key Manufacturers Amlodipine Besylate Covered
Table Global Amlodipine Besylate Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Amlodipine Besylate Sales Market Share by Product 2014-2025
Figure 2.5mg Tablets Product Picture
Table Major Manufacturers of 2.5mg Tablets
Figure 5mg Tablets Product Picture
Table Major Manufacturers of 5mg Tablets
Figure 10mg Tablets Product Picture
Table Major Manufacturers of 10mg Tablets
Table Global Amlodipine Besylate Market Size Growth Rate by End User 2019-2025 (K Units)
Figure High Blood Pressure
Figure Heart Disease
Figure Amlodipine Besylate Report Years Considered
Figure Global Amlodipine Besylate Market Size 2014-2025 (Million US$)
Figure Global Amlodipine Besylate Sales 2014-2025 (K Units)
Table Global Amlodipine Besylate Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Amlodipine Besylate Sales by Regions 2014-2019 (K Units)
Table Global Amlodipine Besylate Sales Market Share by Regions 2014-2019
Figure Global Amlodipine Besylate Sales Market Share by Regions 2014-2019
Figure 2018 Global Amlodipine Besylate Sales Market Share by Regions
Table Global Amlodipine Besylate Revenue by Regions 2014-2019 (Million US$)
Table Global Amlodipine Besylate Revenue Market Share by Regions 2014-2019
Figure Global Amlodipine Besylate Revenue Market Share by Regions 2014-2019
Figure 2018 Global Amlodipine Besylate Revenue Market Share by Regions
Table Global Amlodipine Besylate Sales by Manufacturers (2014-2019) (K Units)
Table Global Amlodipine Besylate Sales Share by Manufacturers (2014-2019)
Figure Global Amlodipine Besylate Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Amlodipine Besylate Revenue by Manufacturers (2014-2019) (Million USD)
Table Amlodipine Besylate Revenue Share by Manufacturers (2014-2019)
Figure Amlodipine Besylate Value Share by Manufacturers in 2018
Table Key Manufacturers Amlodipine Besylate Price (2014-2019) (USD/Unit)
Table Amlodipine Besylate Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Amlodipine Besylate Product Type
Table Date of International Manufacturers Enter into Amlodipine Besylate Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Amlodipine Besylate Sales by Product (2014-2019) (K Units)
Table Global Amlodipine Besylate Sales Share by Product (2014-2019)
Figure Global Amlodipine Besylate Sales Market Share by Product (2014-2019)
Figure Global Amlodipine Besylate Sales Market Share by Product in 2018
Table Global Amlodipine Besylate Revenue by Product (2014-2019) (Million US$)
Table Global Amlodipine Besylate Revenue Share by Product (2014-2019)
Figure Global Amlodipine Besylate Revenue Market Share by Product (2014-2019)
Figure Global Amlodipine Besylate Revenue Market Share by Product in 2018
Table Amlodipine Besylate Price by Product 2014-2019 (USD/Unit)
Table Global Amlodipine Besylate Sales by End User (2014-2019) (K Units)
Table Global Amlodipine Besylate Sales Share by End User (2014-2019)
Figure Global Sales Amlodipine Besylate Market Share by End User (2014-2019)
Figure Global Sales Amlodipine Besylate Market Share by End User in 2018
Figure North America Amlodipine Besylate Sales Growth Rate 2014-2019 (K Units)
Figure North America Amlodipine Besylate Revenue Growth Rate 2014-2019 (Million US$)
Table North America Amlodipine Besylate Sales by Countries (2014-2019) (K Units)
Table North America Amlodipine Besylate Sales Market Share by Countries (2014-2019)
Figure 2018 North America Amlodipine Besylate Sales Market Share by Countries
Table North America Amlodipine Besylate Revenue by Countries (2014-2019) (Million US$)
Table North America Amlodipine Besylate Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Amlodipine Besylate Revenue Market Share by Countries
Figure United States Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure United States Amlodipine Besylate Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Canada Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Table North America Amlodipine Besylate Sales by Product (2014-2019) (K Units)
Table North America Amlodipine Besylate Sales Market Share by Product (2014-2019)
Figure 2018 North America Amlodipine Besylate Market Share by Product
Table North America Amlodipine Besylate Sales by End User (2014-2019) (K Units)
Table North America Amlodipine Besylate Sales Market Share by End User (2014-2019)
Figure 2018 North America Amlodipine Besylate Market Share by End User
Figure Europe Amlodipine Besylate Sales Growth Rate 2014-2019 (K Units)
Figure Europe Amlodipine Besylate Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Amlodipine Besylate Sales by Countries (2014-2019) (K Units)
Table Europe Amlodipine Besylate Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Amlodipine Besylate Sales Market Share by Countries
Table Europe Amlodipine Besylate Revenue by Countries (2014-2019) (Million US$)
Table Europe Amlodipine Besylate Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Amlodipine Besylate Revenue Market Share by Countries
Figure Germany Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Germany Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure France Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure France Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure UK Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Italy Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Russia Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Amlodipine Besylate Sales by Product (2014-2019) (K Units)
Table Europe Amlodipine Besylate Sales Market Share by Product (2014-2019)
Figure 2018 Europe Amlodipine Besylate Market Share by Product
Table Europe Amlodipine Besylate Sales by End User (2014-2019) (K Units)
Table Europe Amlodipine Besylate Sales Market Share by End User (2014-2019)
Figure 2018 Europe Amlodipine Besylate Market Share by End User
Figure Asia Pacific Amlodipine Besylate Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Amlodipine Besylate Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Amlodipine Besylate Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Amlodipine Besylate Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Amlodipine Besylate Sales Market Share by Countries
Table Asia Pacific Amlodipine Besylate Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Amlodipine Besylate Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Amlodipine Besylate Revenue Market Share by Countries
Figure China Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure China Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Japan Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Korea Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure India Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure India Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Australia Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Amlodipine Besylate Sales by Product (2014-2019) (K Units)
Table Asia Pacific Amlodipine Besylate Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Amlodipine Besylate Market Share by Product
Table Asia Pacific Amlodipine Besylate Sales by End User (2014-2019) (K Units)
Table Asia Pacific Amlodipine Besylate Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Amlodipine Besylate Market Share by End User
Figure Central & South America Amlodipine Besylate Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Amlodipine Besylate Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Amlodipine Besylate Sales by Countries (2014-2019) (K Units)
Table Central & South America Amlodipine Besylate Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Amlodipine Besylate Sales Market Share by Countries
Table Central & South America Amlodipine Besylate Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Amlodipine Besylate Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Amlodipine Besylate Revenue Market Share by Countries
Figure Brazil Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Amlodipine Besylate Sales by Product (2014-2019) (K Units)
Table Central & South America Amlodipine Besylate Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Amlodipine Besylate Market Share by Product
Table Central & South America Amlodipine Besylate Sales by End User (2014-2019) (K Units)
Table Central & South America Amlodipine Besylate Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Amlodipine Besylate Market Share by End User
Figure Middle East and Africa Amlodipine Besylate Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Amlodipine Besylate Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Amlodipine Besylate Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Amlodipine Besylate Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Amlodipine Besylate Sales Market Share by Countries
Table Middle East and Africa Amlodipine Besylate Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Amlodipine Besylate Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Amlodipine Besylate Revenue Market Share by Countries
Figure GCC Countries Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Amlodipine Besylate Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Amlodipine Besylate Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Amlodipine Besylate Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Amlodipine Besylate Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Amlodipine Besylate Market Share by Product
Table Middle East and Africa Amlodipine Besylate Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Amlodipine Besylate Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Amlodipine Besylate Market Share by End User
Table Pfizer Company Details
Table Pfizer Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Mylan Company Details
Table Mylan Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr. Reddy's Laboratories Recent Development
Table Apotex Company Details
Table Apotex Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Apotex Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Cipla Company Details
Table Cipla Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cipla Recent Development
Table Hikma Pharmaceuticals Company Details
Table Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hikma Pharmaceuticals Recent Development
Table Strides Pharma Company Details
Table Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Strides Pharma Recent Development
Table Upsher-Smith Laboratories Company Details
Table Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Upsher-Smith Laboratories Recent Development
Table InvaGen Pharmaceuticals Company Details
Table InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table InvaGen Pharmaceuticals Recent Development
Table Sun Pharmaceutical Company Details
Table Aurobindo Pharma Company Details
Table Lupin Pharmaceuticals Company Details
Table Zydus Pharmaceuticals Company Details
Table Oxford Pharm Company Details
Table Wockhardt Company Details
Table Epic Pharma Company Details
Table CR Pharmaceutical Company Details
Table Alkem Laboratories Company Details
Table MACLEODS Company Details
Table Global Amlodipine Besylate Sales Forecast by Regions 2019-2025 (K Units)
Table Global Amlodipine Besylate Sales Market Share Forecast by Regions 2019-2025
Table Global Amlodipine Besylate Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Amlodipine Besylate Revenue Market Share Forecast by Regions 2019-2025
Table Global Amlodipine Besylate Sales Forecast by Product 2019-2025 (K Units)
Table Global Amlodipine Besylate Sales Market Share Forecast by Product 2019-2025
Table Global Amlodipine Besylate Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Amlodipine Besylate Revenue Market Share Forecast by Product 2019-2025
Table Global Amlodipine Besylate Sales Forecast by End User 2019-2025 (K Units)
Table Global Amlodipine Besylate Sales Market Share Forecast by End User 2019-2025
Figure North America Amlodipine Besylate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Amlodipine Besylate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Amlodipine Besylate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Amlodipine Besylate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Amlodipine Besylate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Amlodipine Besylate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Amlodipine Besylate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Amlodipine Besylate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Amlodipine Besylate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Amlodipine Besylate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Amlodipine Besylate Value Chain
Table Amlodipine Besylate Customers List
Table Amlodipine Besylate Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs